JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haque, S. J.
Right arrow Articles by Williams, B. R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haque, S. J.
Right arrow Articles by Williams, B. R. G.

J Biol Chem, Vol. 273, Issue 51, 33893-33896, December 18, 1998

COMMUNICATION
Protein-tyrosine Phosphatase Shp-1 Is a Negative Regulator of IL-4- and IL-13-dependent Signal Transduction

S. Jaharul Haque, Phyllis Harbor, Mina Tabrizi, Taolin Yi, and Bryan R. G. Williams

From the Department of Cancer Biology, The Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195

Binding of interleukin (IL)-4 to its transmembrane receptor results in the Jak-mediated tyrosine phosphorylation of a number of protein components of the IL-4 signaling cascade, including Jak1, Jak2, Jak3, Tyk2, IL-4Ralpha , IRS-1, IRS-2, and Stat6 in appropriate cell types. However, the protein-tyrosine phosphatases (PTPs) that dephosphorylate these proteins and terminate signaling remained unidentified. We have noted that IL-4-dependent activation of Stat6 is sustained longer in fibroblasts than in lymphoid cells. Because Shp-1, an SH2 domain-containing PTP, is expressed primarily in hematopoietic cells, we examined whether Shp-1 activity could regulate IL-4-dependent cell signaling. Expression of an Shp-1 transgene in NIH 3T3 cells markedly reduces both IL-4-dependent Stat6 activation and Stat6-mediated transcription of IL-4-responsive genes. In accord with this, IL-4 treatment of bone marrow-derived macrophages from viable motheaten mice that express substantially reduced levels of Shp-1 activity show remarkably enhanced activation of Stat6. In addition, Stat6 activation by IL-4 is significantly enhanced in pre-B cells derived from motheaten (Shp-1 null mutant) mice compared with normal pre-B cells derived from control animals. These data clearly implicate Shp-1 in the negative regulation of the IL-4/IL-13-activated Jak-Stat pathway.


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
J. Immunol.Home page
T. Zheng, W. Liu, S.-Y. Oh, Z. Zhu, B. Hu, R. J. Homer, L. Cohn, M. J. Grusby, and J. A. Elias
IL-13 Receptor {alpha}2 Selectively Inhibits IL-13-Induced Responses in the Murine Lung
J. Immunol., January 1, 2008; 180(1): 522 - 529.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Gao, H. Guo, Z. Mi, M. J. Grusby, and P. C. Kuo
Osteopontin Induces Ubiquitin-Dependent Degradation of STAT1 in RAW264.7 Murine Macrophages
J. Immunol., February 1, 2007; 178(3): 1870 - 1881.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Kozma, M. Halasz, B. Polgar, T. G. Poehlmann, U. R. Markert, T. Palkovics, M. Keszei, G. Par, K. Kiss, J. Szeberenyi, et al.
Progesterone-Induced Blocking Factor Activates STAT6 via Binding to a Novel IL-4 Receptor
J. Immunol., January 15, 2006; 176(2): 819 - 826.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. M. Stephenson, D.-S. Park, A. L. Mora, S. Goenka, and M. Boothby
Sequence Motifs in IL-4R{alpha} Mediating Cell-Cycle Progression of Primary Lymphocytes
J. Immunol., October 15, 2005; 175(8): 5178 - 5185.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
M. Olivier, D. J. Gregory, and G. Forget
Subversion Mechanisms by Which Leishmania Parasites Can Escape the Host Immune Response: a Signaling Point of View
Clin. Microbiol. Rev., April 1, 2005; 18(2): 293 - 305.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Huang, J. Xin, J. Coleman, and H. Huang
IFN-{gamma} Suppresses STAT6 Phosphorylation by Inhibiting Its Recruitment to the IL-4 Receptor
J. Immunol., February 1, 2005; 174(3): 1332 - 1337.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
N. Wood, M. J. Whitters, B. A. Jacobson, J. Witek, J. P. Sypek, M. Kasaian, M. J. Eppihimer, M. Unger, T. Tanaka, S. J. Goldman, et al.
Enhanced Interleukin (IL)-13 Responses in Mice Lacking IL-13 Receptor {alpha} 2
J. Exp. Med., March 17, 2003; 197(6): 703 - 709.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. M. Hanson, H. Dickensheets, C.-K. Qu, R. P. Donnelly, and A. D. Keegan
Regulation of the Dephosphorylation of Stat6. PARTICIPATION OF TYR-713 IN THE INTERLEUKIN-4 RECEPTOR alpha , THE TYROSINE PHOSPHATASE SHP-1, AND THE PROTEASOME
J. Biol. Chem., January 31, 2003; 278(6): 3903 - 3911.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. R. Wu, Y. K. Hong, X.-D. Wang, M. Y. Ling, A. M. Dragoi, A. S. Chung, A. G. Campbell, Z.-Y. Han, G.-S. Feng, and Y. E. Chin
SHP-2 Is a Dual-specificity Phosphatase Involved in Stat1 Dephosphorylation at Both Tyrosine and Serine Residues in Nuclei
J. Biol. Chem., November 27, 2002; 277(49): 47572 - 47580.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Yamada, D. Zhu, A. Saxon, and K. Zhang
CD45 Controls Interleukin-4-mediated IgE Class Switch Recombination in Human B Cells through Its Function as a Janus Kinase Phosphatase
J. Biol. Chem., August 2, 2002; 277(32): 28830 - 28835.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Deng, A. Minguela, R. Z. Hussain, A. E. Lovett-Racke, C. Radu, E. S. Ward, and M. K. Racke
Expression of the Tyrosine Phosphatase Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase 1 Determines T Cell Activation Threshold and Severity of Experimental Autoimmune Encephalomyelitis
J. Immunol., May 1, 2002; 168(9): 4511 - 4518.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. D. Zapata, R. M. Ropero, A. M. Valencia, L. Buscail, J. I. Lopez, R. M. Martin-Orozco, J. C. Prieto, J. Angulo, C. Susini, P. Lopez-Ruiz, et al.
Autocrine Regulation of Human Prostate Carcinoma Cell Proliferation by Somatostatin through the Modulation of the SH2 Domain Containing Protein Tyrosine Phosphatase (SHP)-1
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 915 - 926.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. O. Rahaman, P. Sharma, P. C. Harbor, M. J. Aman, M. A. Vogelbaum, and S. J. Haque
IL-13R{alpha}2, a Decoy Receptor for IL-13 Acts As an Inhibitor of IL-4-dependent Signal Transduction in Glioblastoma Cells
Cancer Res., February 1, 2002; 62(4): 1103 - 1109.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Kashiwada, C. C. Giallourakis, P.-Y. Pan, and P. B. Rothman
Immunoreceptor Tyrosine-Based Inhibitory Motif of the IL-4 Receptor Associates with SH2-Containing Phosphatases and Regulates IL-4-Induced Proliferation
J. Immunol., December 1, 2001; 167(11): 6382 - 6387.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. C. Webb, A. N. J. McKenzie, and P. S. Foster
Expression of the Ym2 Lectin-binding Protein Is Dependent on Interleukin (IL)-4 and IL-13 Signal Transduction. IDENTIFICATION OF A NOVEL ALLERGY-ASSOCIATED PROTEIN
J. Biol. Chem., November 2, 2001; 276(45): 41969 - 41976.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. S. Wang, E. Zorn, and J. Ritz
Specific down-regulation of interleukin-12 signaling through induction of phospho-STAT4 protein degradation
Blood, June 15, 2001; 97(12): 3860 - 3866.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
E. D. White, R. P. Andrews, and G. K. K. Hershey
Sulfhydryl-2 domain-containing protein tyrosine phosphatase-1 is not a negative regulator of interleukin-4 signaling in murine mast cells
J. Leukoc. Biol., May 1, 2001; 69(5): 825 - 830.
[Abstract] [Full Text]


Home page
BloodHome page
R. D. Chernock, R. P. Cherla, and R. K. Ganju
SHP2 and cbl participate in {alpha}-chemokine receptor CXCR4-mediated signaling pathways
Blood, February 1, 2001; 97(3): 608 - 615.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Q. Zhang, P. N. Raghunath, E. Vonderheid, N. Odum, and M. A. Wasik
Lack of Phosphotyrosine Phosphatase SHP-1 Expression in Malignant T-Cell Lymphoma Cells Results from Methylation of the SHP-1 Promoter
Am. J. Pathol., October 1, 2000; 157(4): 1137 - 1146.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. R. Stofega, J. Herrington, N. Billestrup, and C. Carter-Su
Mutation of the SHP-2 Binding Site in Growth Hormone (GH) Receptor Prolongs GH-Promoted Tyrosyl Phosphorylation of GH Receptor, JAK2, and STAT5B
Mol. Endocrinol., September 1, 2000; 14(9): 1338 - 1350.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D.-Q. Guo, L.-W. Wu, J. D. Dunbar, O. N. Ozes, L. D. Mayo, K. M. Kessler, J. A. Gustin, M. R. Baerwald, E. A. Jaffe, R. S. Warren, et al.
Tumor Necrosis Factor Employs a Protein-tyrosine Phosphatase to Inhibit Activation of KDR and Vascular Endothelial Cell Growth Factor-induced Endothelial Cell Proliferation
J. Biol. Chem., April 6, 2000; 275(15): 11216 - 11221.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Pauza, K. M. Smith, H. Neal, C. Reilly, L. L. Lanier, and D. Lo
Transgenic Expression of Ly-49A in Thymocytes Alters Repertoire Selection
J. Immunol., January 15, 2000; 164(2): 884 - 892.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. Hill, E. Herlaar, A. Le Cardinal, G. van Heeke, and P. Nicklin
Homologous Human and Murine Antisense Oligonucleotides Targeting Stat6 . Functional Effects on Germline Cepsilon Transcript
Am. J. Respir. Cell Mol. Biol., December 1, 1999; 21(6): 728 - 737.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
M. L. Janas, P. Hodgkin, M. Hibbs, and D. Tarlinton
Genetic Evidence for Lyn as a Negative Regulator of IL-4 Signaling
J. Immunol., October 15, 1999; 163(8): 4192 - 4198.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. K. Ganju, S. A. Brubaker, R. D. Chernock, S. Avraham, and J. E. Groopman
beta -Chemokine Receptor CCR5 Signals through SHP1, SHP2, and Syk
J. Biol. Chem., June 2, 2000; 275(23): 17263 - 17268.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Tanuma, K. Nakamura, H. Shima, and K. Kikuchi
Protein-tyrosine Phosphatase PTPepsilon C Inhibits Jak-STAT Signaling and Differentiation Induced by Interleukin-6 and Leukemia Inhibitory Factor in M1 Leukemia Cells
J. Biol. Chem., September 1, 2000; 275(36): 28216 - 28221.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Haque, P. C. Harbor, and B. R. G. Williams
Identification of Critical Residues Required for Suppressor of Cytokine Signaling-specific Regulation of Interleukin-4 Signaling
J. Biol. Chem., August 18, 2000; 275(34): 26500 - 26506.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.